June 13, 2023
Dr. Kyu Rhee to Address Hospital & Pharmacy Lab Innovation in the Age of Big Data and Primary Care Transformation in Upcoming Webinar
(SAN DIEGO, CA) – XiFin announced today that Kyu Rhee, M.D., MPP, will serve as Senior Strategic Advisor to help drive acceptance for expanded payor coverage of pharmacist-provided clinical services through medical benefits and the convergence of diagnostics and therapy. Dr. Rhee serves as a physician executive across the healthcare industry, and most recently, was Senior Vice President and Aetna Chief Medical Officer at CVS Health.
“Dr. Rhee is a nationally-recognized public and private sector health care leader who has spent much of his career working to improve our nation’s health system, especially for underserved and health disparity populations,” said David Pope, PharmD, CDE, chief pharmacy officer, XiFin. “He knows firsthand how valuable the evolution of the pharmacy-based clinical care service model is to filling provider voids and delivering the kind of convenient, integrated, patient-centric care expected today.”
Dr. Rhee will work with XiFin’s pharmacy division, OmniSYS, to build momentum behind the national movement to broaden and make permanent pharmacists’ role as proven providers of clinical services to help address physician shortages and improve healthcare access for the nation’s most vulnerable and underserved communities.
“Advocacy for our customers and the patients they serve is at the core of our company’s mission, and Dr. Rhee’s depth and breadth of experience, along with his vast personal network of national healthcare leaders among payors, providers, and government leaders will be invaluable in this collaboration,” said Kyle Fetter, XiFin’s Chief Operating Officer.
Dr. Rhee’s work will include support for passage of bipartisan legislation in Congress, the Equitable Community Access to Pharmacist Services Act (H.R. 1770), to provide pharmacy reimbursement under Medicare part B for testing and treatment of COVID-19, influenza, respiratory syncytial virus, streptococcal pharyngitis, and for certain vaccine services.
“XiFin and OmniSYS have been at the forefront of industry advocacy for years, and I’m eager to work together to affect positive change in healthcare access through the acceleration of the expanding role pharmacists play as members of primary care teams,” said Rhee. “Most people interact with their pharmacist more often than they do their doctors, creating an immense opportunity to empower pharmacists to offer a range of clinical services and to serve at-risk populations by improving health care access in care deserts and amid a worsening primary care shortage.”
While at CVS Health, Dr. Rhee led a team of over 1,500 doctors, nurses, pharmacists, and other health professionals in the integration and delivery of clinical and population health solutions to improve health for up to 65 million people via commercial, Medicare, Medicaid, behavioral health, and other plans. This essential work enabled providers and patients to assure the right care at the right time through 850+ evidence-based clinical policies and activated 900+ data scientists using data, analytics, and artificial intelligence.
He previously served for a decade as Vice President and Chief Health Officer at IBM, where he was the lead physician, public health, and clinical executive leader for the company’s global workforce of over 350,000 in 170 countries. He had global responsibilities for IBM’s efforts to transform health through the use of data, analytics, artificial intelligence, and services for hospitals, health systems, providers, health plans, employers, governments, and life science companies.
Dr. Rhee also served as Chief Public Health Officer at the Human Resources and Services Administration (HRSA) and Director of Innovation at the National Institutes of Health (NIH). While at HRSA and NIH, he led numerous national initiatives related to prevention, health care quality, research, health equity and public health.
On Wednesday, June 14th at 12:00 pm CT, Dr. Rhee will join a panel discussion hosted by Becker’s Hospital Review: “Thriving Amidst Disruption: Innovating Hospital Labs and Pharmacies for the Future in the Age of Big Data and Primary Care Transformation” to explore the evolving landscape of hospital labs and pharmacies amidst rapid innovation and emerging competition. Joining Dr. Rhee in the discussion are Jane Hermansen, Manager, Outreach and Network Development, Mayo Clinic, and Dean Braun, Senior Vice President, OmniSYS | XiFin Pharmacy Solutions.
XIFIN is a healthcare information technology company that leverages diagnostic information to improve the quality and economics of healthcare. The company’s cloud-based technology facilitates connectivity and workflow automation for accessing and sharing clinical and financial diagnostic data, linking healthcare stakeholders in the delivery and reimbursement of care across diagnostic, pharmacy and oncology markets. The company provides cross-specialty industry analytics including its Lab Volume Index which provides a measurement of laboratory testing volumes across the US. Its synthesis of diagnostic data enables comparisons of hospital, genetics, pathology, routine lab, COVID-19, and antibody testing across key segments. To learn more, visit www.XIFIN.com, follow XIFIN on Twitter and LinkedIn, or subscribe to the XIFIN blog.